[go: up one dir, main page]

DK320587D0 - Nye farmakologiske forbindelser - Google Patents

Nye farmakologiske forbindelser

Info

Publication number
DK320587D0
DK320587D0 DK320587A DK320587A DK320587D0 DK 320587 D0 DK320587 D0 DK 320587D0 DK 320587 A DK320587 A DK 320587A DK 320587 A DK320587 A DK 320587A DK 320587 D0 DK320587 D0 DK 320587D0
Authority
DK
Denmark
Prior art keywords
relations
new pharmacological
compounds
pharmacological
new
Prior art date
Application number
DK320587A
Other languages
Danish (da)
English (en)
Other versions
DK320587A (da
Inventor
Tomas Boerje Alminger
Haakan Sigurd Larsson
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK320587D0 publication Critical patent/DK320587D0/da
Publication of DK320587A publication Critical patent/DK320587A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
DK320587A 1985-10-29 1987-06-24 Nye farmakologiske forbindelser DK320587A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds
PCT/SE1986/000493 WO1987002668A1 (en) 1985-10-29 1986-10-28 Novel pharmacological compounds

Publications (2)

Publication Number Publication Date
DK320587D0 true DK320587D0 (da) 1987-06-24
DK320587A DK320587A (da) 1987-06-24

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK320587A DK320587A (da) 1985-10-29 1987-06-24 Nye farmakologiske forbindelser

Country Status (31)

Country Link
US (1) US5021433A (pl)
EP (2) EP0221041A3 (pl)
JP (2) JPH0780874B2 (pl)
KR (1) KR950009858B1 (pl)
CN (1) CN1022487C (pl)
AT (1) ATE79619T1 (pl)
AU (1) AU598491B2 (pl)
CS (1) CS272767B2 (pl)
DD (1) DD252375A5 (pl)
DE (1) DE3686483T2 (pl)
DK (1) DK320587A (pl)
EG (1) EG17753A (pl)
ES (1) ES2051696T3 (pl)
FI (1) FI91151C (pl)
GR (1) GR3006177T3 (pl)
HU (1) HU198474B (pl)
IE (1) IE59167B1 (pl)
IL (1) IL80437A0 (pl)
IS (1) IS1564B (pl)
JO (1) JO1502B1 (pl)
LT (1) LTIP1681A (pl)
LV (1) LV10270B (pl)
MY (1) MY101791A (pl)
NO (1) NO171365C (pl)
NZ (1) NZ218028A (pl)
PH (1) PH25319A (pl)
PL (1) PL150240B1 (pl)
PT (1) PT83647B (pl)
SE (1) SE8505112D0 (pl)
WO (1) WO1987002668A1 (pl)
ZA (1) ZA867716B (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
EP0436025A4 (en) * 1988-09-20 1991-09-11 Hisamitsu Pharmaceutical Co. Inc. Novel dibenz b,e)oxepin derivatives
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
ATE184602T1 (de) * 1990-06-20 1999-10-15 Astra Ab Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
DE69905171T2 (de) 1998-08-10 2003-11-20 Dept Of Veterans Affairs Washi Prodrugs für proton-pump-inhibitoren
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
EP1334971A4 (en) * 2000-10-12 2004-05-12 Takeda Chemical Industries Ltd BENZIMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF
WO2003027098A1 (fr) * 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci
DE60328603D1 (de) * 2002-06-14 2009-09-10 Takeda Pharmaceutical Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
PL375255A1 (pl) * 2002-07-19 2005-11-28 Winston Pharmaceuticals Llc Proleki inhibitorów pompy protonowej
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
BRPI0507784A (pt) * 2004-02-18 2007-07-17 Allergan Inc métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
US20070161679A1 (en) * 2004-02-18 2007-07-12 Allergan, Inc. Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
JP2007532677A (ja) * 2004-04-16 2007-11-15 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
US7176319B2 (en) 2004-04-28 2007-02-13 Hetero Drugs Limited Process for substituted sulfoxides
PT1748998E (pt) 2004-05-28 2010-03-24 Hetero Drugs Ltd Novo processo de síntese estereoselectiva de sulfóxidos de benzimidazol
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008036201A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
US9107911B2 (en) 2010-01-07 2015-08-18 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (pl) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives

Also Published As

Publication number Publication date
HUT43843A (en) 1987-12-28
IE862805L (en) 1987-04-29
MY101791A (en) 1992-01-31
ZA867716B (en) 1987-05-27
PH25319A (pl) 1991-04-30
IL80437A0 (en) 1987-01-30
NO872686L (no) 1987-06-26
JPH0826014B2 (ja) 1996-03-13
WO1987002668A1 (en) 1987-05-07
JPS63501151A (ja) 1988-04-28
JPH07188216A (ja) 1995-07-25
NO872686D0 (no) 1987-06-26
PT83647B (pt) 1989-05-31
PL262105A1 (en) 1988-08-18
ES2051696T3 (es) 1994-07-01
EP0233284B1 (en) 1992-08-19
NO171365C (no) 1993-03-03
FI91151B (fi) 1994-02-15
AU598491B2 (en) 1990-06-28
HU198474B (en) 1989-10-30
EP0221041A3 (en) 1987-10-28
LV10270A (lv) 1994-10-20
CN86107595A (zh) 1987-07-08
DE3686483D1 (de) 1992-09-24
FI91151C (sv) 1994-05-25
NZ218028A (en) 1990-02-26
LTIP1681A (en) 1995-09-25
GR3006177T3 (pl) 1993-06-21
KR950009858B1 (ko) 1995-08-29
AU6542986A (en) 1987-05-19
DE3686483T2 (de) 1993-02-04
PL150240B1 (en) 1990-05-31
FI872864L (fi) 1987-06-29
IS1564B (is) 1994-12-13
CS782686A2 (en) 1990-05-14
DD252375A5 (de) 1987-12-16
EG17753A (en) 1991-12-30
PT83647A (en) 1986-11-01
CS272767B2 (en) 1991-02-12
FI872864A0 (fi) 1987-06-29
NO171365B (no) 1992-11-23
IE59167B1 (en) 1994-01-12
LV10270B (en) 1995-04-20
CN1022487C (zh) 1993-10-20
IS3156A7 (is) 1987-04-30
KR870700620A (ko) 1987-12-30
SE8505112D0 (sv) 1985-10-29
JO1502B1 (en) 1989-01-25
EP0233284A1 (en) 1987-08-26
US5021433A (en) 1991-06-04
DK320587A (da) 1987-06-24
EP0221041A2 (en) 1987-05-06
ATE79619T1 (de) 1992-09-15
JPH0780874B2 (ja) 1995-08-30

Similar Documents

Publication Publication Date Title
NO872686D0 (no) Nye farmakologiske forbindelser.
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
MY101784A (en) Novel pharmacological compounds
SE8404065D0 (sv) Novel biologically active compounds
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
SE8405588D0 (sv) New compounds
SE8704049D0 (sv) Novel pharmacological compounds
IT1224404B (it) Composti attivi sul sistema cardiovascolare

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment